Lexicon Pharmaceuticals Research and Development Day Webcast
Webcast Alert: Lexicon Pharmaceuticals, Inc. Announces Webcast of Annual Research & Development Day

THE WOODLANDS, Texas, Dec. 3 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) announces the following Webcast:

    What:     Lexicon Pharmaceuticals Research and Development Day Webcast

    When:     Wednesday, December 5th @ 12 Noon, Eastern

    Where:    Webcast link will be available at http://www.lexpharma.com or at
              http://www.videonewswire.com/event.asp?id=44188

    How:      Live over the Internet -- Simply log on to the web at the
              address above, or by using the link at Lexicon's website.

If you are unable to participate during the live Webcast, the call will be archived on the Web site, http://www.lexpharma.com, until December 12, 2007.

Lexicon is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon currently has clinical programs underway for such areas of major unmet medical need as irritable bowel syndrome and cognitive disorders. The company has used its proprietary gene knockout technology to discover more than 100 promising drug targets and create an extensive pipeline of clinical and preclinical programs in the therapeutic areas of diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders and ophthalmic disease. To advance the development and commercialization of its programs, Lexicon is working both independently and through collaborators including Bristol-Myers Squibb Company, Genentech, Inc. and N.V. Organon. For additional information about Lexicon and its programs, please visit http://www.lexpharma.com.

Source: Lexicon Pharmaceuticals

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here